SCHEMBL28548813

SCHEMBL28548813

N#Cc1ccc2ncccc2c1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
KDM4E B2RXH2 2/20 0.52
LRRK2 Q5S007 2/20 0.45
CYP3A4 P08684 1/20 0.43
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
HTT P42858 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
HIF1A Q16665 1/20 0.42
ELANE P08246 2/20 0.38
ERN1 O75460 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
IMPDH2 P12268 1/20 0.36
IMPDH1 P20839 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8144149 0.80 MAPT (0.61) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL25487988 0.80 KDM4E (0.54) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL12489213 0.79 MAPT (0.52) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL566054 0.76 MAPT (0.52) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL12986264 0.75 MAPT (0.52) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL1998666 0.75 MAPT (0.52) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL21872084 0.75 MAPT (0.47) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL21871906 0.75 MAPT (0.47) MAPTKDM4ELRRK2CYP3A4LMNA
SCHEMBL25156689 0.74 HTT (0.44) MAPTKDM4ELRRK2MEN1HTT
SCHEMBL1997158 0.72 LMNA (0.51) MAPTKDM4ELRRK2CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638901-A Novel pyrrolidinylamide compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2021-04-09 CN disclosed